Cover Image

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer

Saved in:

Bibliographic Details
Date:	2018
Main Author:	D. E. Ryspayeva
Format:	Article
Language:	English
Published:	2018
Series:	Oncology
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0001148818
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)

Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023)

Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
by: N. A. Bondarovich, et al.
Published: (2008)

Prognostic value of blood redox-state indicators in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2018)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)

Topoisomerase IIα determins the prognosis and response to chemotherapy in patients with operable breast cancer
by: D. E. Ryspaeva, et al.
Published: (2017)

Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)

Second-line chemotherapy in patients with advanced gastric cancer
by: V. G. Bondar, et al.
Published: (2014)

Combination of chemotherapy and immunotherapy in cancer patients treatment (review)
by: N. E. Prokhach, et al.
Published: (2017)

Secondary edematous breast cancer: when to be operated on background of neo-adjuvant chemotherapy?
by: O. M. Bilyi, et al.
Published: (2019)

Expression of anti-apoptothic protein survivin and gene BIRC5 in primary breast carcinoma as a prognostic marker for progression of disease
by: Ya. A. Shliakhtunou
Published: (2018)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)

Characterization of breast cancer DNA content profiles as a prognostic tool
by: Gerashchenko, B.I., et al.
Published: (2014)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)

Characterization of breast cancer DNA content profiles as a prognostic tool
by: B. I. Gerashchenko, et al.
Published: (2014)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: S. Akyurek, et al.
Published: (2013)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: Akyurek, S., et al.
Published: (2013)

Interplay of host genome and tumour genome in bladder cancer
by: M. P. Smal, et al.
Published: (2019)

Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
by: A. I. Rybin, et al.
Published: (2018)

Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
by: A. A. Mikhanovskij, et al.
Published: (2014)

Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)

The expression of markers of epithelial-mesenchymal transition and drug resistance proteins as a prognostic indicator in patients with colorectal cancer
by: N. O. Bezdieniezhnykh, et al.
Published: (2016)

CD8 and CD45RO T lymphocytes in bone marrow of gastric cancer patients: correlation with disseminated tumor cells and disease outcome
by: S. Osinsky, et al.
Published: (2015)

Expression of epithelial-mesenchymal transition-related genes in prostate tumours
by: Gerashchenko, G.V., et al.
Published: (2017)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)

Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
by: N. O. Verovkina, et al.
Published: (2017)

Human microbiota and effectiveness of cancer chemotherapy
by: Shvets, Yu.V., et al.
Published: (2023)

Androgen deprivation therapy in combination with chemotherapy in patients with castrate-naive metastatic prostate cancer
by: A. N. Dubinina
Published: (2016)

The ways to optimize the treatment of patients with regional breast cancer
by: V. H. Dubinina, et al.
Published: (2017)

Study of trace elements status of breast cancer patients
by: M. N. Tillashaykhov, et al.
Published: (2017)

Superroxide radicals: initiation of metastases in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2017)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)

Efficiency of high dose chemotherapy with transplantation of autologous stem cells in patients with prognostically unfavorable variants of hodgkin&#039;s lymphoma
by: N. V. Minaeva, et al.
Published: (2008)

Immunohistochemical and biochemical analysis of mammary gland tumours of different age patients
by: T. Lykholat, et al.
Published: (2016)

Integral characteristic of the immune system state predicts breast cancer outcome
by: Stakheyeva, M., et al.
Published: (2023)

Individualization of neoadjuvant therapy in patients with locally-distributed breast cancer
by: Ju. Ju. Belevtsova
Published: (2019)